A single arm phase 2 study of talimogene laherparepvec in patients with low-risk invasive cutaneous squamous cell cancer. interim analysis - Curiel, Clara N; Stratton, Delaney; Cui, Haiyan; Roe, Denise; Arif Tiwari, Hina; Sundararajan, Srinath (Journal of clinical oncology, 2022)